Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Intangibles: 2020-2025

Historic Intangibles for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to $643,000.

  • Mereo BioPharma Group's Intangibles fell 19.52% to $643,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $643,000, marking a year-over-year decrease of 19.52%. This contributed to the annual value of $643,000 for FY2024, which is 40.96% down from last year.
  • Mereo BioPharma Group's Intangibles amounted to $643,000 in Q3 2025, which was up 36.81% from $470,000 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma Group's Intangibles registered a high of $33.1 million during Q4 2021, and its lowest value of $470,000 during Q2 2025.
  • Over the past 3 years, Mereo BioPharma Group's median Intangibles value was $721,000 (recorded in 2024), while the average stood at $754,500.
  • Data for Mereo BioPharma Group's Intangibles shows a maximum YoY plummeted of 45.73% (in 2025) over the last 5 years.
  • Over the past 5 years, Mereo BioPharma Group's Intangibles (Quarterly) stood at $33.1 million in 2021, then fell by 2.09% to $30.4 million in 2022, then reached $1.1 million in 2023, then plummeted by 40.96% to $643,000 in 2024, then declined by 19.52% to $643,000 in 2025.
  • Its Intangibles stands at $643,000 for Q3 2025, versus $470,000 for Q2 2025 and $554,000 for Q1 2025.